Should we be using intraarticular tumor necrosis factor blockade in inflammatory monoarthritis?

Benjamin A C Fisher, Andrew Keat

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish
Pages (from-to)1934-5
Number of pages2
JournalThe Journal of Rheumatology
Volume33
Issue number10
Publication statusPublished - Oct 2006

Keywords

  • Adalimumab
  • Antibodies, Monoclonal/administration & dosage
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents/administration & dosage
  • Arthritis/drug therapy
  • Dose-Response Relationship, Drug
  • Etanercept
  • Humans
  • Immunoglobulin G/administration & dosage
  • Infliximab
  • Injections, Intra-Articular
  • Receptors, Tumor Necrosis Factor/administration & dosage
  • Tumor Necrosis Factor-alpha/antagonists & inhibitors

Cite this